Case Studies: Things you need to know about China partnering

Case Studies: Things you need to know about China partnering

In 2018, Chinese companies made more than 150 cross-border life sciences licensing deals, with the average upfront payment of ~$10 Million, having reached a record high. Over 40% of early- and late-stage assets entered China market through licensing deals.  In this...

Top China VCs who matters in healthcare, but you hardly know

Forbes released its annual Midas List of the best dealmakers in venture capital and the Chinese were outstanding in the 2019 rankings. Selected Deals in 2019 Apic Bio completed a $40 million Series A financing led by Morningside Venture Cullgen of San Diego Raises $16...

Will You Interested In Partnering With These Chinese Organizations

MyBioGate Global Healthcare Innovation Competition is a cross-border platform that connects global innovations in healthcare with the growing market, capital, and resources in China. We aim to help companies from overseas find out and connect with trustworthy Chinese...

Last Call For The MyBioGate Competition Hamburg Preliminary

Do you have a therapeutic, medical device or digital health product that has great potential in China’s healthcare market? Are you seeking manufacturers, distributors or clinical partners to help you succeed in the global market? Are you a fundraising CEO...